Nine medicine samples manufactured by various pharmaceutical firms in Himachal Pradesh are among 50 drugs declared substandard nationwide by the Central Drugs Standard Control Organisation (CDSCO) in its monthly alert issued today.
Various reasons such as description, power of hydrogen (pH), presence of particulate matter, sterility, dissolution, fineness of dispersion and disintegration have been stated as the reasons for failure. Navneet Marwaha, State Drugs Controller, said the batches declared substandard would be immediately withdrawn from the market. He said show-cause notices had been issued to all firms and the drug inspectors had been directed to inquire whether the conditions to issue licence were being adhered to. Further action as per the findings would be undertaken, he said. Among the pharmaceutical units, Zee Laboratories (Paonta Sahib) had repetitively figured on the list. Assistant Drugs Controller (Paonta Sahib) Sunny Kaushal said actions such as suspension and withdrawal of product permissions had been taken over the past few months when the company’s samples failed.
Bioreva Dublin, a brand of Bioreva Sciences Limited, recognized for its unique skincare solutions, has entered the Indian market in collaboration with Zee Laboratories Limited, launching products such as Eye Repair Cream with patented Mulitsal Delive
The idea is simply to offer products that work on your key skin issues, and to break the clutter by bringing in targeted and hyper-concentrated ingredients.